Literature DB >> 28105922

Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer.

Anastasiya Vladimirovna Snezhkina1, George Sergeevich Krasnov1,2, Andrew Rostislavovich Zaretsky3, Alex Zhavoronkov4, Kirill Mikhailovich Nyushko2, Alexey Alexandrovich Moskalev1,5, Irina Yurievna Karpova1, Anastasiya Isaevna Afremova1, Anastasiya Valerievna Lipatova1, Dmitriy Vladimitovich Kochetkov1, Maria Sergeena Fedorova1, Nadezhda Nikolaevna Volchenko2, Asiya Fayazovna Sadritdinova1,2, Nataliya Vladimirovna Melnikova1, Dmitry Vladimirovich Sidorov2, Anatoly Yurievich Popov6, Dmitry Valerievich Kalinin7, Andrey Dmitrievich Kaprin2, Boris Yakovlevich Alekseev2, Alexey Alexandrovich Dmitriev1, Anna Viktorovna Kudryavtseva8,9.   

Abstract

BACKGROUND: Colorectal cancer (CRC) is one of the most common malignant tumors worldwide. CRC molecular pathogenesis is heterogeneous and may be followed by mutations in oncogenes and tumor suppressor genes, chromosomal and microsatellite instability, alternative splicing alterations, hypermethylation of CpG islands, oxidative stress, impairment of different signaling pathways and energy metabolism. In the present work, we have studied the alterations of alternative splicing patterns of genes related to energy metabolism in CRC.
RESULTS: Using CrossHub software, we analyzed The Cancer Genome Atlas (TCGA) RNA-Seq datasets derived from colon tumor and matched normal tissues. The expression of 1014 alternative mRNA isoforms involved in cell energy metabolism was examined. We found 7 genes with differentially expressed alternative transcripts whereas overall expression of these genes was not significantly altered in CRC. A set of 8 differentially expressed transcripts of interest has been validated by qPCR. These eight isoforms encoded by OGDH, COL6A3, ICAM1, PHPT1, PPP2R5D, SLC29A1, and TRIB3 genes were up-regulated in colorectal tumors, and this is in concordance with the bioinformatics data. The alternative transcript NM_057167 of COL6A3 was also strongly up-regulated in breast, lung, prostate, and kidney tumors. Alternative transcript of SLC29A1 (NM_001078177) was up-regulated only in CRC samples, but not in the other tested tumor types.
CONCLUSIONS: We identified tumor-specific expression of alternative spliced transcripts of seven genes involved in energy metabolism in CRC. Our results bring new knowledge on alternative splicing in colorectal cancer and suggest a set of mRNA isoforms that could be used for cancer diagnosis and development of treatment methods.

Entities:  

Keywords:  Adenocarcinoma; Alternative splicing; Colorectal cancer; Energy metabolism; Tumor-specific alternative mRNA transcripts

Mesh:

Substances:

Year:  2016        PMID: 28105922      PMCID: PMC5249009          DOI: 10.1186/s12864-016-3351-5

Source DB:  PubMed          Journal:  BMC Genomics        ISSN: 1471-2164            Impact factor:   3.969


  106 in total

Review 1.  Turning on a fuel switch of cancer: hnRNP proteins regulate alternative splicing of pyruvate kinase mRNA.

Authors:  Mo Chen; Jian Zhang; James L Manley
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 3.  Soluble intercellular adhesion molecule-1 (sICAM-1): an overview.

Authors:  Anna Maria Witkowska; Maria Halina Borawska
Journal:  Eur Cytokine Netw       Date:  2004 Apr-Jun       Impact factor: 2.737

Review 4.  Treatment of metastatic colorectal cancer.

Authors:  Janine M Davies; Richard M Goldberg
Journal:  Semin Oncol       Date:  2011-08       Impact factor: 4.929

5.  Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity.

Authors:  J C Becker; R Dummer; A A Hartmann; G Burg; R E Schmidt
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

6.  IDH1 and IDH2: not your typical oncogenes.

Authors:  Zachary J Reitman; D Williams Parsons; Hai Yan
Journal:  Cancer Cell       Date:  2010-03-16       Impact factor: 31.743

7.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Authors:  Arun Sreekumar; Laila M Poisson; Thekkelnaycke M Rajendiran; Amjad P Khan; Qi Cao; Jindan Yu; Bharathi Laxman; Rohit Mehra; Robert J Lonigro; Yong Li; Mukesh K Nyati; Aarif Ahsan; Shanker Kalyana-Sundaram; Bo Han; Xuhong Cao; Jaeman Byun; Gilbert S Omenn; Debashis Ghosh; Subramaniam Pennathur; Danny C Alexander; Alvin Berger; Jeffrey R Shuster; John T Wei; Sooryanarayana Varambally; Christopher Beecher; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-02-12       Impact factor: 49.962

8.  Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells.

Authors:  Y Nakano; S Tanno; K Koizumi; T Nishikawa; K Nakamura; M Minoguchi; T Izawa; Y Mizukami; T Okumura; Y Kohgo
Journal:  Br J Cancer       Date:  2007-01-16       Impact factor: 7.640

9.  Identification of key genes associated with gastric cancer based on DNA microarray data.

Authors:  Hui Sun
Journal:  Oncol Lett       Date:  2015-11-17       Impact factor: 2.967

Review 10.  Important molecular genetic markers of colorectal cancer.

Authors:  Anna V Kudryavtseva; Anastasia V Lipatova; Andrew R Zaretsky; Alexey A Moskalev; Maria S Fedorova; Anastasiya S Rasskazova; Galina A Shibukhova; Anastasiya V Snezhkina; Andrey D Kaprin; Boris Y Alekseev; Alexey A Dmitriev; George S Krasnov
Journal:  Oncotarget       Date:  2016-08-16
View more
  19 in total

1.  The Dihydroorotate Dehydrogenase Inhibitor Brequinar Is Synergistic with ENT1/2 Inhibitors.

Authors:  Christine R Cuthbertson; Hui Guo; Armita Kyani; Joseph T Madak; Zahra Arabzada; Nouri Neamati
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-23

2.  Mutational load in carotid body tumor.

Authors:  Anna V Kudryavtseva; Elena N Lukyanova; Dmitry V Kalinin; Andrew R Zaretsky; Anatoly V Pokrovsky; Alexander L Golovyuk; Maria S Fedorova; Elena A Pudova; Sergey L Kharitonov; Vladislav S Pavlov; Anastasiya A Kobelyatskaya; Nataliya V Melnikova; Alexey A Dmitriev; Andrey P Polyakov; Boris Y Alekseev; Marina V Kiseleva; Andrey D Kaprin; George S Krasnov; Anastasiya V Snezhkina
Journal:  BMC Med Genomics       Date:  2019-03-13       Impact factor: 3.063

Review 3.  Next-generation sequencing: recent applications to the analysis of colorectal cancer.

Authors:  Filippo Del Vecchio; Valentina Mastroiaco; Antinisca Di Marco; Chiara Compagnoni; Daria Capece; Francesca Zazzeroni; Carlo Capalbo; Edoardo Alesse; Alessandra Tessitore
Journal:  J Transl Med       Date:  2017-12-08       Impact factor: 5.531

4.  Profiles of differentially expressed genes and overexpression of NEBL indicates a positive prognosis in patients with colorectal cancer.

Authors:  Xiao Qiu; Jue-Rong Feng; Fan Wang; Peng-Fei Chen; Xiao-Xing Chen; Rui Zhou; Ying Chang; Jing Liu; Qiu Zhao
Journal:  Mol Med Rep       Date:  2017-12-07       Impact factor: 2.952

5.  Upregulation of NETO2 gene in colorectal cancer.

Authors:  Maria S Fedorova; Anastasiya V Snezhkina; Elena A Pudova; Ivan S Abramov; Anastasiya V Lipatova; Sergey L Kharitonov; Asiya F Sadritdinova; Kirill M Nyushko; Kseniya M Klimina; Mikhail M Belyakov; Elena N Slavnova; Nataliya V Melnikova; Maria A Chernichenko; Dmitry V Sidorov; Marina V Kiseleva; Andrey D Kaprin; Boris Y Alekseev; Alexey A Dmitriev; Anna V Kudryavtseva
Journal:  BMC Genet       Date:  2017-12-28       Impact factor: 2.797

6.  Effect of long non-coding RNA Gas5 on proliferation, migration, invasion and apoptosis of colorectal cancer HT-29 cell line.

Authors:  Hai-Juan Xiao; Jun-Ming Hou; Jin Li; Yuan Wang; Cheng-Gong Zhang; Jing-Dong He
Journal:  Cancer Cell Int       Date:  2018-01-04       Impact factor: 5.722

Review 7.  The emerging role and targetability of the TCA cycle in cancer metabolism.

Authors:  Nicole M Anderson; Patrick Mucka; Joseph G Kern; Hui Feng
Journal:  Protein Cell       Date:  2017-07-26       Impact factor: 14.870

8.  Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer.

Authors:  Haifeng Lian; Aili Wang; Yuanyuan Shen; Qian Wang; Zhenru Zhou; Ranran Zhang; Kun Li; Chengxia Liu; Hongtao Jia
Journal:  BMC Gastroenterol       Date:  2020-06-05       Impact factor: 3.067

Review 9.  The Biological Role of the Collagen Alpha-3 (VI) Chain and Its Cleaved C5 Domain Fragment Endotrophin in Cancer.

Authors:  Jingya Wang; Wensheng Pan
Journal:  Onco Targets Ther       Date:  2020-06-22       Impact factor: 4.147

10.  Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways associated with TP53 expression status in HBV-related hepatocellular carcinoma.

Authors:  Xiwen Liao; Long Yu; Xiaoguang Liu; Chuangye Han; Tingdong Yu; Wei Qin; Chengkun Yang; Guangzhi Zhu; Hao Su; Tao Peng
Journal:  Cancer Manag Res       Date:  2018-05-01       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.